A U.S. appeals court has vacated a decision from the U.S. Patent and Trademark Office (USPTO), reviving a spat between Recor Medical and Medtronic. The patent battle centers around renal denervation (RDN) technology for treating hypertension. Recor and Medtronic are the two leaders in this space, with Recor Medical receiving an FDA nod for its Paradise […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The top 10 cardiac device stories of 2024
+ The latest AI-powered cardiology devices you need to know
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Intuitive aims at the heart with a new cardiac surgery leader
Three decades after Intuitive Surgical launched to develop surgical robotics for cardiac surgeries before finding success in a range of other procedures, the company may be renewing its focus on the heart. Darla Hutton today announced her new role as Intuitive’s global VP of cardiac surgery, saying on LinkedIn she’ll “be going back, in a […]
Boston Scientific closes Bolt Medical acquisition
Boston Scientific announced on social media that it completed its previously announced acquisition of Bolt Medical. News of the acquisition’s closing comes just days after the FDA granted 510(k) clearance for the Bolt IVL system on March 25, about two months post-submission (Jan. 27). The company wrote on LinkedIn: “We have successfully closed the acquisition […]
Johnson & Johnson has positive dual-energy ablation data
Johnson & Johnson MedTech announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch SF catheter. The medtech giant said investigators presented findings at the annual meeting of the European Heart Rhythm Association (EHRA) in Vienna, Austria. Outcomes showed that the dual-energy catheter proved 86.9% effective when treating patients with high adherence to […]
The biggest cardiology tech news out of ACC 2025
Chicago was the site for the latest edition of the American College of Cardiology (ACC) Scientific Sessions. There, a number of the biggest names in heart technology shared clinical findings highlighting the latest innovations in the space. Study data highlighted the benefits of technologies including replacement heart valves, monitors and more. Companies like Medtronic, Edwards, […]
iRhythm data highlights benefits of Zio long-term heart monitoring
iRhythm Technologies announced results from two large, real-world analyses demonstrating the benefits of its Zio system. The retrospective analyses drew on data from more than 1.1 million patients using Zio long-term continuous monitoring ECG devices. Investigators presented findings at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago. Results demonstrated that short-term (24-48-hour) […]
Teleflex wins FDA nod for intra-aortic balloon pump
Teleflex announced today that it received FDA 510(k) clearance for its AC Range intra-aortic balloon pump (IABP). The AC3 Range IABP joins the company’s expanding portfolio of IABPs, including the AC3 Optimus. Teleflex designed them to provide reliable, ongoing IABP support across various patient transport modes. That includes ambulances and fixed- and rotary- wing aircrafts. […]
Edwards shares data supporting timely TAVR intervention
Edwards Lifesciences today announced new data supporting its heart valve replacement technologies. Investigators shared findings from multiple studies at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo in Chicago. Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best strategy for treating asymptomatic […]
JenaValve data backs TAVR system for treating aortic regurgitation
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system. The ALIGN-AR pivotal trial evaluated Trilogy in high-risk patients with symptomatic, severe aortic regurgitation (AR). The expanded cohort of 500 patients represented the largest prospective study of transcatheter aortic valve replacement (TAVR), JenaValve said. In a January report, […]
MiRus kicks off Siegel heart valve early feasibility study
MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV). Dr. Pradeep K. Yadav and Dr. Vinod H. Thourani successfully performed the first two cases with the 8-Fr aortic THV. Both patients were discharged from Piedmont Heart Institute (Atlanta) without complications the next day. The latest development […]
FDA clears Boston Scientific Bolt IVL system
Boston Scientific has received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA’s 510(k) database. According to the FDA, it granted 510(k) clearance for the system on March 25, about two months post-submission (Jan. 27). The database included the RESTORE ATK (above the knee) trial for Bolt IVL in treating stenotic […]
